Gümligen, Switzerland

Werner Müller


 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Gumligen, CH (1992 - 1994)
  • Gümligen, CH (2015 - 2016)

Company Filing History:


Years Active: 1992-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Werner Müller: A Pioneer in Pharmaceutical Innovations

Introduction

Werner Müller, based in Gümligen, Switzerland, is an accomplished inventor with a focus on pharmaceutical innovations. He holds two notable patents that showcase his expertise in the field of medicinal chemistry. His work contributes significantly to the advancement of pharmaceutical compositions and related processes, ultimately aiming to improve healthcare outcomes.

Latest Patents

One of Werner Müller’s key inventions is centered around 1-aza-bicyclo[3.3.1]nonanes. This patent pertains to 1-aza-bicycloalkyl derivatives of Formula (I). The invention outlines specific substituents and their roles in the production processes, pharmaceutical utilization, and the creation of pharmaceutical compositions comprising these compounds. The patent details intricate formulas, wherein substituents such as A and Y have precise functionalities, contributing to the effective application of these compounds in the pharmaceutical industry.

Career Highlights

Werner Müller is currently affiliated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to engage in pioneering research aimed at developing innovative pharmaceutical solutions. Through his contributions, Müller strengthens the company's position in the pharmaceutical sector and brings groundbreaking innovations to the market.

Collaborations

Throughout his career, Werner has collaborated with esteemed colleagues, including Dominik Feuerbach and Bernard Lucien Roy. These partnerships enable a rich exchange of ideas and expertise, enhancing the development of novel therapeutics and encouraging innovative research in pharmaceuticals.

Conclusion

Werner Müller is a prominent figure in the realm of pharmaceutical inventions. His contributions, particularly in the area of 1-aza-bicyclo[3.3.1]nonanes, represent a significant advancement in medicinal chemistry. As he continues to work with Novartis AG and his talented colleagues, the impact of his innovations is sure to resonate within the healthcare industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…